All News

David Liew Tweet
drdavidliew
Can hs-troponin and hsCRP predict future major cardiovascular events? Certainly appears so in RA pts (n=636). To what extent do subclinical dx and inflammation combine to cause future RA CV pain? PRECISION trial subgroup @ElaineHusniMD @DanielHSolomon #ACR20 ABST1189 @RheumNow https://t.co/ZYTpodatVI
David Liew Tweet
drdavidliew
The lung-joint axis in RA just keeps on getting stronger Lung ACPA present in early untreated RA/CSA: crossreact acetylated/carbamylated antigens differ in effects on cell types (neut activation, fibroblasts, osteoclasts) Isn't lung ACPA fascinating? #ACR20 ABST1445 @RheumNow https://t.co/9VKSRYlndT
Dr. Antoni Chan Tweet
synovialjoints
In our quest to reduce delays to diagnosis in axSpA, this paper in patients with psoriasis, AAU and IBD, the ASAS-modification of the Berlin algorithm was superior to the original algorithm, with enhanced sensitivity @RheumNow #ACR20 Abstr#1303
Robert B Chao, MD Tweet
doctorRBC
NT-proBNP and TnI predicted cardiovascular events in patients with PsO or PsA. Abs#1328 Do you measure/monitor for cardiovascular disease in your psoriatic patients? @RheumNow #ACR20
David Liew Tweet
drdavidliew
Nintedanib in rheum ILD (RA/SSc/CTD) I appreciate the volumes might not seem like much, but: - in first 1y Rx 20% more are spared a FVC decline>10% - biggest diff in UIP-like pattern With the right patient selection, nintedanib does have its place! #ACR20 ABST1048/1049 @RheumNow https://t.co/jGZdR84bBU
alexa meara Tweet
lexmeara
So much more work to be done- the traditional tools for estimating CVD in rheumatic patients are likely not accurate especially patients with SLE- abstract 1286 @RheumNow #acr20 https://t.co/L6Z1fsO2he
Meral K. El Ramahi, MD Tweet
MeralElRamahiMD
Do you obtain baseline and/or serial TTE, EKG, BNP, and TROPONIN* on follow-up visits of your patients with myositis? #ACR20 @RheumNow
Meral K. El Ramahi, MD Tweet
MeralElRamahiMD
Do you obtain baseline and/or serial TTE, EKG, and BNP on follow-up visits of your patients with myositis? #ACR20 @RheumNow
Dr. Dinesh Khanna Tweet
sclerodermaUM
@RichardPAConway @DrDDRheum @DrErickZamora1 @hoffmann_vold @RheumNow YES! Why? 'Normal' echo in 1/3 of patients with early PAH. Screening# Diagnosis. Below is data where echo and RHC was done at the same time. in those with eRVSP < 36, 36% had RHC- derived PAH. https://t.co/W2YiyZnwwV
Richard Conway Tweet
RichardPAConway
Dr Cai presents risk of CVD in gout in study 450,000 patients. Gout was independently associated with an increased risk of CVD events HR = 1.24 for women; 1.21 for men. @rheumnow #ACR20 Abstr#950 #ACRbest https://t.co/089aKtN5a7
David Liew Tweet
drdavidliew
Nice insights into RA-ILD from @jeffsparks: - assoc (in Medicare): male, smoker, asthma/COPD, b/tsDMARDs, steroids - mortality risk? Yes, esp resp (sdHR 4.4), cancer - ACPA/lung inflamm related to RA-ILD? Yes, esp anti-filaggrin (aOR 3.08/log unit) #ACR20 ABST0489/0490 @RheumNow https://t.co/DGkNNPOcbd
Eric Dein Tweet
ejdein1
Does your pt have myocardial inflamm? Trop specific but not sensitive, BNP neither sens or specific. Consider EKG - sensitive (85%), but non-specific- But TTE is essential and cMRI is best! #ACR20 @RheumNow Great lecture from cardiologist, @HopkinsBayview APD https://t.co/6THm37KbQ3
Janet Pope Tweet
Janetbirdope
Most ignore pharmacists annoying faxes re safety of QT interval with #hydroxycholoroquine likely the right thing to do! @RheumNow #ACR2020 @CRASCRRheum abstr#431. https://t.co/pXBIDOV2MP
Dr. Antoni Chan Tweet
synovialjoints
In the search for biomarkers in PsA, interesting study showing absolute lymphocyte count is negatively correlated with cardiovascular disease risk score and red cell distribution width and increases with TNF-Inhibitor Therapy @rheumnow #ACR20 Abstr#878
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×